467 related articles for article (PubMed ID: 35130731)
1. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
3. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
6.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
7. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
8. Colon Cancer-Associated
Abed J; Maalouf N; Manson AL; Earl AM; Parhi L; Emgård JEM; Klutstein M; Tayeb S; Almogy G; Atlan KA; Chaushu S; Israeli E; Mandelboim O; Garrett WS; Bachrach G
Front Cell Infect Microbiol; 2020; 10():400. PubMed ID: 32850497
[No Abstract] [Full Text] [Related]
9.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
10.
Brennan CA; Clay SL; Lavoie SL; Bae S; Lang JK; Fonseca-Pereira D; Rosinski KG; Ou N; Glickman JN; Garrett WS
Gut Microbes; 2021; 13(1):1987780. PubMed ID: 34781821
[TBL] [Abstract][Full Text] [Related]
11.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
12. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
13. Tumour microbiomes and Fusobacterium genomics in Vietnamese colorectal cancer patients.
Tran HNH; Thu TNH; Nguyen PH; Vo CN; Doan KV; Nguyen Ngoc Minh C; Nguyen NT; Ta VND; Vu KA; Hua TD; Nguyen TNT; Van TT; Pham Duc T; Duong BL; Nguyen PM; Hoang VC; Pham DT; Thwaites GE; Hall LJ; Slade DJ; Baker S; Tran VH; Chung The H
NPJ Biofilms Microbiomes; 2022 Oct; 8(1):87. PubMed ID: 36307484
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.
Kostic AD; Chun E; Robertson L; Glickman JN; Gallini CA; Michaud M; Clancy TE; Chung DC; Lochhead P; Hold GL; El-Omar EM; Brenner D; Fuchs CS; Meyerson M; Garrett WS
Cell Host Microbe; 2013 Aug; 14(2):207-15. PubMed ID: 23954159
[TBL] [Abstract][Full Text] [Related]
15. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
Huang X; Hong X; Wang J; Sun T; Yu T; Yu Y; Fang J; Xiong H
EBioMedicine; 2020 Nov; 61():103037. PubMed ID: 33039709
[TBL] [Abstract][Full Text] [Related]
16. Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with
Borozan I; Zaidi SH; Harrison TA; Phipps AI; Zheng J; Lee S; Trinh QM; Steinfelder RS; Adams J; Banbury BL; Berndt SI; Brezina S; Buchanan DD; Bullman S; Cao Y; Farris AB; Figueiredo JC; Giannakis M; Heisler LE; Hopper JL; Lin Y; Luo X; Nishihara R; Mardis ER; Papadopoulos N; Qu C; Reid EEG; Thibodeau SN; Harlid S; Um CY; Hsu L; Gsur A; Campbell PT; Gallinger S; Newcomb PA; Ogino S; Sun W; Hudson TJ; Ferretti V; Peters U
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):210-220. PubMed ID: 34737207
[TBL] [Abstract][Full Text] [Related]
17.
Engevik MA; Danhof HA; Ruan W; Engevik AC; Chang-Graham AL; Engevik KA; Shi Z; Zhao Y; Brand CK; Krystofiak ES; Venable S; Liu X; Hirschi KD; Hyser JM; Spinler JK; Britton RA; Versalovic J
mBio; 2021 Mar; 12(2):. PubMed ID: 33653893
[TBL] [Abstract][Full Text] [Related]
18. Genome-Based Reclassification of Fusobacterium nucleatum Subspecies at the Species Level.
Kook JK; Park SN; Lim YK; Cho E; Jo E; Roh H; Shin Y; Paek J; Kim HS; Kim H; Shin JH; Chang YH
Curr Microbiol; 2017 Oct; 74(10):1137-1147. PubMed ID: 28687946
[TBL] [Abstract][Full Text] [Related]
19. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
[TBL] [Abstract][Full Text] [Related]
20. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]